Data / Drug companies / Usv Private Limited
Usv Private Limited: 43 products in the FDA NDC directory, labeler code 62147
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Usv Private Limited (labeler code 62147) lists 43 products in the FDA National Drug Code Directory. By type: 43 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on December 12, 2024.
The request: Watch Usv Private Limited (FDA labeler code 62147): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 62147
- Products in commercial distribution
- 43
- Packages
- 46
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- August 5, 2009
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 43 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 43 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 40 | 93% |
| Granule | 2 | 4.7% |
| Liquid | 1 | 2.3% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Empagliflozin | 62147-0289 | Powder | Bulk ingredients | December 12, 2024 |
| Rivaroxan | 62147-0287 | Powder | Bulk ingredients | December 10, 2024 |
| Dapagliflozin (dapagliflozin 30% w/w solution in isopropyl alcohol) | 62147-0282 | Liquid | Bulk ingredients | November 28, 2022 |
| Etelcalcetide hydrochloride | 62147-0281 | Powder | Bulk ingredients | December 6, 2021 |
| Ticagrelor | 62147-0280 | Powder | Bulk ingredients | December 4, 2021 |
| Trimetazidine dihydrochloride | 62147-0279 | Powder | Bulk ingredients | December 12, 2020 |
| Regadenoson | 62147-0292 | Powder | Bulk ingredients | December 24, 2019 |
| Sugammadex sodium | 62147-0278 | Powder | Bulk ingredients | December 20, 2019 |
| Icatibant acetate | 62147-0277 | Powder | Bulk ingredients | December 20, 2019 |
| Palonosetron hydrochloride | 62147-0218 | Powder | Bulk ingredients | April 11, 2014 |
| Metformin hydrochloride | 62147-0197 | Granule | Bulk ingredients | July 27, 2011 |
| Octreotide | 62147-0206 | Powder | Bulk ingredients | September 1, 2010 |
| Metformin hydrochloride | 62147-0016 | Powder | Bulk ingredients | April 16, 2010 |
| Metformin hydrochloride | 62147-0100 | Powder | Bulk ingredients | April 12, 2010 |
| Metformin hydrochloride | 62147-0102 | Granule | Bulk ingredients | April 9, 2010 |
| Metformin hydrochloride | 62147-0099 | Powder | Bulk ingredients | March 24, 2010 |
| Ropinirole hydrochloride | 62147-0008 | Powder | Bulk ingredients | February 23, 2010 |
| Pioglitazone hydrochloride | 62147-0071 | Powder | Bulk ingredients | February 19, 2010 |
| Pioglitazone hydrochloride | 62147-0070 | Powder | Bulk ingredients | February 19, 2010 |
| Pioglitazone hydrochloride | 62147-0020 | Powder | Bulk ingredients | February 11, 2010 |
| Pioglitazone hydrochloride | 62147-0005 | Powder | Bulk ingredients | February 4, 2010 |
| Ropinirole hydrochloride | 62147-0015 | Powder | Bulk ingredients | January 22, 2010 |
| Zoledronic acid | 62147-0125 | Powder | Bulk ingredients | January 4, 2010 |
| Repaglinide | 62147-0055 | Powder | Bulk ingredients | December 18, 2009 |
| Repaglinide | 62147-0013 | Powder | Bulk ingredients | December 17, 2009 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.